Where to buy lpilimumab?

Ipilimumab (Ipilimumab) is an immunotherapy drug used to treat malignant melanoma, a type of malignant cutaneous melanoma, often referred to simply as melanoma. It is the first immunotherapy drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma, providing a new treatment option for patients with advanced melanoma.

Ipilimumab is not currently available in China, so patients cannot purchase it domestically and can only purchase it through overseas purchase channels. There are only original drugs of Ipilimumab abroad, mainly Turkish original drugs and Bristol-Myers Squibb original drugs. The price of Turkish original drugs is around 12,000 yuan, and the specification is 50mg/10ml; Bristol-Myers Squibb's original drug costs about 11,700 yuan, and its specifications are also 50mg/10ml. The ingredients of the two drugs are the same.

Ipilimumab works by activating the immune system and enhancing the body's immune response to cancer cells. Melanoma often has a mechanism to avoid immune system attack, making traditional cancer treatments of limited effectiveness. Ipilimumab inhibits the function of CTLA-4 (cytotoxicTlymphocyte-associated antigen4) protein. It can prevent its activation on T lymphocytes, thereby increasing the activity of T lymphocytes so that they can attack and destroy melanoma cells more effectively.

However, ipilimumab is not a drug without risks, as it may cause a series of immune-related side effects, including intestinal inflammation, skin reactions, liver damage, etc. Therefore, when using ipilimumab to treat melanoma, doctors need to carefully monitor the patient's immune system response and take appropriate steps to manage and mitigate side effects.